Preface -- Acknowledgments -- Introduction : The pharmacopoeia of risk reduction -- pt. 1. Diuril and hypertension, 1957-1977 -- 1. Releasing the flood waters : the development and promotion of Diuril -- 2. Shrinking the symptom, growing the disease : hypertension after Diuril -- pt. 2. Orinase and diabetes, 1960-1980 -- 3. Finding the hidden diabetic : Orinase creates a new market -- 4. Risk and the symptom : the trials of Orinase -- pt. 3. Mevacor and cholesterol, 1970-2000 -- 5. The fall and rise of a risk factor : cholesterol and its remedies -- 6. Know your number : cholesterol and the threshold of pathology -- Conclusion : the therapeutic transition -- Notes -- Index
Bibliography
Includes bibliographical references (pages 241-308) and index
